Opko Health Company Leadership
| OPK Stock | USD 1.35 0.03 2.17% |
Opko Health employs about 3 K people. The company is managed by 17 executives with a total tenure of roughly 37 years, averaging almost 2.0 years of service per executive, having 176.29 employees per reported executive. Inspection of Opko Health's management performance can provide insight into the company performance.
| Phillip Frost Chairman Chairman of the Board, CEO |
| Akhtar Ashfaq President Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division |
Opko Health Management Team Effectiveness
The company has Return on Asset of (0.082) % which means that on every $100 spent on assets, it lost $0.082. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0304) %, meaning that it generated no profit with money invested by stockholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities.Opko Health Workforce Comparison
Opko Health is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 4,925. Opko Health totals roughly 2,997 in number of employees claiming about 61% of equities under Health Care industry.
The company has Net Profit Margin of (0.06) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.45) %, which entails that for every $100 of revenue, it lost $0.45. Opko Health Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opko Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opko Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Opko Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Opko Health Notable Stakeholders
An Opko Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Opko Health often face trade-offs trying to please all of them. Opko Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Opko Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Elias MD | President Chairman | Profile | |
| Phillip Frost | Chairman of the Board, CEO | Profile | |
| Arie Gutman | President API | Profile | |
| David Okrongly | President Diagnostics | Profile | |
| Antonio Cruz | President Therapeutics | Profile | |
| Hans Berner | President Iberoamerica | Profile | |
| Akhtar Ashfaq | Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division | Profile | |
| Adam Logal | CFO, Chief Accounting Officer, Sr. VP and Treasurer | Profile | |
| Dr MBA | Vice Officer | Profile | |
| FACP FASN | Senior Renal | Profile | |
| JD Esq | Chief Laboratories | Profile | |
| Charles Bishop | Chief Renal | Profile | |
| James DeMarco | VP Sales | Profile | |
| Giovanni MD | Chief Officer | Profile | |
| MBA MBA | Vice Officer | Profile | |
| Jon MD | Advisor | Profile | |
| Damien Burke | Chief Pharma | Profile |
About Opko Health Management Performance
The success or failure of an entity such as Opko Health often depends on how effective the management is. Opko Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Opko management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Opko management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company was founded in 1991 and is headquartered in Miami, Florida. Opko Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5767 people.
Opko Health Workforce Analysis
Traditionally, organizations such as Opko Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Opko Health within its industry.Opko Health Manpower Efficiency
Return on Opko Health Manpower
| Revenue Per Employee | 238K | |
| Revenue Per Executive | 41.9M | |
| Net Loss Per Employee | 17.8K | |
| Net Loss Per Executive | 3.1M | |
| Working Capital Per Employee | 156.5K | |
| Working Capital Per Executive | 27.6M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.